Conceptio › Archive › Europe PMC
Europe PMCopen access

Influence of oncogenic drivers and signaling pathways on immune checkpoint inhibitor efficacy in NSCLC

Liu C et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
immunotherapynon-small-cell-lung-cancertumor-microenvironment
Immunotherapy, Non-small cell lung cancer, Tyrosine kinase inhibitor, Tumor Microenvironment, Signaling Pathway Inhibitor Or Agonist
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1015719
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.